CJC-1295 (No DAC) Price: What Research-Grade Actually Costs

At a glance: CJC-1295 (No DAC) pricing & quality benchmark

The market price for cjc 1295 without Drug Affinity Complex (DAC) directly reflects the rigor of its synthesis, purification, and analytical verification. Lower upfront cost often masks severe quality deficits, such as sequence truncation, high trifluoroacetic acid (TFA) salt residue, or elevated endotoxin levels that disrupt in vitro assays.

A true research-grade CJC-1295 (No DAC) vial includes independent HPLC chromatograms verifying strictly >99% purity, liquid chromatography-mass spectrometry (LC-MS) confirming exact molecular weight (3298.2 g/mol), and limulus amebocyte lysate (LAL) testing guaranteeing sub-0.5 EU/mg endotoxin levels.

To review current tier pricing, lot data, and volume options, visit our live catalog to order 2 mg or 5 mg vials of Retatrutide or browse our complete selection of research peptides for lab evaluation.

What drives the true price of CJC-1295 (No DAC)?

Understanding the price structure of custom or catalog peptides requires looking at the step-by-step chemical production process. Solid-phase peptide synthesis (SPPS) for a 29-amino-acid chain like Mod GRF 1-29 requires strict coupling efficiency at every single step. Achieving a purity baseline above 98% or 99% demands automated peptide synthesizers operating under controlled temperature, precise reaction times, and high-purity amino acid precursors.

Beyond raw solid-phase synthesis, preparative High-Performance Liquid Chromatography (HPLC) purification represents a major cost center. Removing closely eluting deletion sequences—truncated peptides missing just one amino acid—requires specialized stationary phase columns and high volumes of HPLC-grade solvents. Suppliers that cut costs often truncate column run times, leaving significant chemical impurities inside the final lyophilized cake.

Finally, domestic quality control and labor contribute to the baseline cost. Operating ISO 9001-certified facilities within the United States, utilizing third-party analytical laboratories for independent assay validation, and maintaining climate-controlled inventory storage require substantial infrastructure investment that guarantees reproducible experimental outcomes.

Chemical structure and mechanism of action

CJC-1295 without DAC—chemically designated as Modified GRF (1-29)—is a synthetic 29-amino-acid peptide analog of naturally occurring Growth Hormone-Releasing Hormone (GHRH). By substituting specific amino acids at positions 2, 8, 15, and 27 (D-Ala2, Gln8, Ala15, and Leu27), the peptide resists enzymatic cleavage by dipeptidyl peptidase IV (DPP-IV), extending its biological half-life in vitro from a few minutes to approximately 30 minutes.

In preclinical research models, CJC-1295 (No DAC) functions as a selective GHRH receptor agonist. Upon binding to the GHRH receptor on pituitary somatotrophs, it activates the adenylate cyclase-CAMP pathway, inducing a physiological, pulsatile release of endogenous growth hormone (GH). In turn, sustained GH signaling stimulates downstream insulin-like growth factor 1 (IGF-1) synthesis, making it a pivotal tool for tissue repair research, cellular regeneration, and metabolic signaling studies.

Red flags in low-cost peptide listings: The invisible risks

When comparing cjc no dac prices across online vendors, suspiciously cheap listings almost always indicate compromised manufacturing or incomplete testing protocols. The most frequent hidden defect is mass underfilling, where a vial labeled as 5 mg contains only 2.5 mg or 3 mg of active peptide blended with excess mannitol or glycine filler.

Another major risk in bargain-tier peptides is unremoved trifluoroacetic acid (TFA). During solid-phase peptide cleavage, TFA salts bind to the basic residues of the peptide. If a supplier skips the salt-exchange step (converting TFA salts to acetate or hydrochloride forms), high residual TFA causes cellular toxicity in cell culture assays and distorts baseline mass measurements.

Most critically, unverified vendors frequently omit endotoxin testing. Bacterial lipopolysaccharides (LPS) introduced during handling or purification can provoke massive inflammatory responses in animal models, invalidating gene expression, cytokine, and metabolic tissue data. True research-grade material must always include an explicit endotoxin specification on its lot certificate.

Comparing CJC No DAC vs. CJC with DAC in research budgets

A critical budget and experimental consideration is choosing between cjc no dac and its longer-acting counterpart, CJC-1295 with DAC (Drug Affinity Complex). While CJC-1295 with DAC forms a covalent bond with serum albumin to extend plasma half-life to several days, it produces continuous, non-pulsatile GH elevation. This sustained signaling can alter pituitary receptor dynamics in extended models.

Conversely, CJC-1295 (No DAC) preserves natural pulsatile GH kinetics, making it ideal for studies mimicking biological release patterns. Because CJC-1295 (No DAC) requires more frequent administration in animal models to maintain elevated biological activity, total peptide mass requirements per study protocol may be higher. Researchers must factor both vial unit price and total study mass consumption into their procurement decisions. Learn more about alternative sequence structures by evaluating our full CJC-1295 with DAC catalog.

The CJC 1295 and Ipamorelin synergy in preclinical literature

In contemporary metabolic and endocrinology research, cjc ipamorelin combinations represent one of the most widely published dual-agonist protocols. While CJC-1295 (No DAC) acts directly on the pituitary GHRH receptor to stimulate GH synthesis, ghrelin receptor agonists like Ipamorelin target the Growth Hormone Secretagogue Receptor (GHSR-1a) to trigger immediate GH vesicle release.

Preclinical data show that co-administration of a GHRH analog and a GHRP results in a synergistic—rather than additive—growth hormone response. When planning multi-compound studies, sourcing both peptides from a single vendor with matching lot-traceability ensures consistent molar ratios and eliminates variability between reagent batches. Check our live pricing to buy CJC-1295 (No DAC) for research alongside co-factor compounds.

Evaluating vendor transparency: Key criteria for lab buyers

To ensure experimental repeatability and avoid wasting laboratory resources, researchers should evaluate prospective peptide vendors against six strict, objective criteria:

1. Purity Verification: HPLC chromatograms must show clear peak separation with primary peak area exceeding 98% or 99%.

2. Structural Identity: Mass spectrometry (MS) report matching theoretical molecular weight exactly, verifying correct sequence assembly.

3. Endotoxin Data: Quantitative LAL test results showing endotoxins below 0.5 EU/mg.

4. Lot Traceability: Unique lot numbers printed on the physical vial matching the analytical COA directly.

5. Storage & Stability: Lyophilized under sterile, vacuum-sealed conditions with proper moisture controls.

6. Fulfillment Infrastructure: Shipped from domestic USA facilities with cold-chain protection to prevent heat-induced degradation.

Why analytical testing (HPLC/MS & endotoxin) adds real value

The analytical testing workflow represents a significant portion of a peptide's final market price, but it is non-negotiable for publishable scientific research. High-Performance Liquid Chromatography (HPLC) separates chemical components in a sample, quantifying the exact ratio of desired target peptide to residual impurities.

Mass Spectrometry (MS) then measures the mass-to-charge ratio of the purified sample, confirming that no amino acid substitutions or unintended side-chain modifications occurred during synthesis. Finally, Limulus Amebocyte Lysate (LAL) testing measures bacterial endotoxin contaminants.

Skipping these analytical procedures reduces unit cost for discount vendors, but shifts immense risk onto the buying laboratory. Utilizing unverified reagents risks experimental failure, non-reproducible data, and compromised cell cultures. PX1 Research publishes full analytical documentation for every lot directly on our research documentation hub.

Red flags checklist: How to vet a research peptide vendor

Before submitting a purchase order or inputting payment details, verify whether your peptide supplier exhibits any of the following critical red flags:

• Generic or Photoshopped COAs: Certificates that lack a specific lot number, date, or clear laboratory contact details.

• Lack of Endotoxin Reporting: Suppliers that provide basic HPLC graphs but omit microbial and endotoxin assays completely.

• Unrealistic Low Pricing: Prices significantly below the baseline cost of raw amino acid coupling reagents and HPLC solvent consumption.

• Foreign Direct Shipping without Cold Chain: Extended international transit times in uninsulated packaging expose lyophilized peptides to high ambient temperatures, causing structural cleavage.

• Vague Entity Information: Overseas distributors masking their origin without verified domestic US administrative or dispatch facilities.

Ordering CJC-1295 (No DAC) from PX1 Research

PX1 Research simplifies high-purity procurement for academic institutions, private biotechnology firms, and independent contract research organizations. Every lot of CJC-1295 (No DAC) is synthesized in state-of-the-art facilities, rigorously purified, and packaged in protective glass vials engineered for long-term stability under sub-zero storage conditions.

We ship directly from our domestic logistics hubs in California and Arizona. Orders placed Monday through Friday before 3:00 PM EST qualify for same-day dispatch, backed by expedited, fully tracked carrier delivery to prevent transit delay and heat exposure.

Each shipment includes complete lot documentation accessible via QR code or direct download. For custom bulk requirements, structural quotes, or institutional procurement accounts, explore our wholesale peptide program or navigate to our primary product page to order CJC-1295 (No DAC) vials today.